基于原发性乳腺癌超声影像组学分析的列线图:预测腋窝淋巴结肿瘤负荷
本研究纳入343例T1/T2浸润性乳腺癌患者,基于原发灶超声影像组学特征联合年龄和病灶大小构建列线图,预测腋窝淋巴结转移负荷(低负荷<3枚,高负荷≥3枚)。训练组AUC为0.846(95%CI 0.790-0.902),验证组AUC为0.733(95%CI 0.613-0.852),校准曲线显示预测与观察一致。作者认为该列线图预测准确性高,并建议进一步完善PyRadiomics以改进超声影像组学。
要点
- 列线图基于超声影像组学评分联合年龄和病灶直径,用于预测T1/T2浸润性乳腺癌腋窝淋巴结负荷。
- 训练组中29.1%(69/237)患者病理诊断为≥3枚转移性腋窝淋巴结,验证组为32.08%(34/106)。
- 模型训练组AUC 0.846(95%CI 0.790-0.902),验证组AUC 0.733(95%CI 0.613-0.852),校准曲线一致性良好。
核心结论
- 基于超声影像组学的列线图在预测乳腺癌腋窝淋巴结肿瘤负荷方面表现出较高准确性,作者建议进一步完善PyRadiomics以改进超声影像组学。
研究设计与样本
- 回顾性研究,纳入2016年8月至2018年11月间343例组织学证实为恶性乳腺肿瘤的患者,按7:3随机分为训练组和验证组;影像组学特征采用PyRadiomics包提取,影像组学评分通过最小绝对收缩和选择算子回归建立,列线图基于多因素逻辑回归结果结合年龄和病灶大小构建。
关键影像表现/征象
- 列线图由16个超声影像组学特征构成的影像组学评分、患者年龄及超声识别的病灶直径共同构建。
- 校准曲线显示预测值与观察值之间具有良好一致性。
诊断标准与关键数值
- 腋窝淋巴结肿瘤负荷定义为低负荷(<3枚转移性腋窝淋巴结)或高负荷(≥3枚转移性腋窝淋巴结)。
- 训练组中29.1%(69/237)患者病理诊断为超过2枚转移性腋窝淋巴结,验证组为32.08%(34/106)。
- 模型训练组AUC为0.846(95%CI 0.790-0.902),验证组AUC为0.733(95%CI 0.613-0.852)。
临床应用与阅片要点
- 作者认为该列线图可协助临床医生评估T1/T2浸润性乳腺癌的治疗策略。
- 作者建议进一步完善PyRadiomics以改进超声影像组学。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To establish a prediction model for evaluating the axillary lymph node (ALN) status of patients with T1/T2 invasive breast cancer based on radiomics analysis of US images of primary breast lesions.
METHODS: Between August 2016 and November 2018, a total of 343 patients with histologically proven malignant breast tumors were included in this study and randomly assigned to the training and validation groups at a ratio of 7:3. ALN tumor burden was defined as low (< 3 metastatic ALNs) or high (≥ 3 metastatic ALNs). Radiomics features were obtained using the PyRadiomics package, and the radiomics score was established by least absolute shrinkage and selection operator regression. A nomogram combining the breast cancer US radiomics score with patient age and lesion size was generated based on the multivariate logistic regression results.
RESULTS: In the training and validation cohorts, 29.1% (69/237) and 32.08% (34/106) of patients were pathologically diagnosed with more than 2 metastatic ALNs, respectively. The radiomics score consisted of 16 US features, and patient age and lesion diameter identified by US were included to construct the model. The AUC of the model was 0.846 (95% CI, 0.790-0.902) for the training cohort and 0.733 (95% CI, 0.613-0.852) for the validation cohort. The calibration curves showed good agreement between the predictions and observations.
CONCLUSIONS: Our novel nomogram demonstrates high accuracy in predicting ALN tumor burden in breast cancer patients. We also suggest further development of PyRadiomics to improve US radiomics.
KEY POINTS: • A nomogram based on US was developed to predict ALN tumor burden (low, < 3 metastatic ALNs; high, ≥ 3 metastatic ALNs). • The nomogram could assist clinicians in evaluating treatment strategies for T1/T2 invasive breast cancer.
引用
- Gao Y, Luo Y, Zhao C, et al. Nomogram based on radiomics analysis of primary breast cancer ultrasound images: prediction of axillary lymph node tumor burden in patients. Eur Radiol. 2020. PMID: 32845388. doi:10.1007/s00330-020-07181-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。